Standard Family Office’s Medpace MEDP Stock Holding History

Standard Family Office’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22	Closed	-$3K	–	269
2022 Q3	$3K	Hold	22	–	–	﹤0.01%	355
2022 Q2	$3K	Buy	+22	New	+$3.19K	0.03%	145

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Standard Family Office's MEDP Position: Q4 2022 in Review

Standard Family Office sold out of Medpace (MEDP) in Q4 2022, closing a stake of 22 shares — an estimated $3K sold.

Standard Family Office first reported a position in MEDP in Q2 2022 and held it in 2 quarters. The position peaked at $3K in Q3 2022. 422 funds tracked by Wall St. Rank hold MEDP as of Q4 2022.

Standard Family Office reported no remaining Medpace position as of Q4 2022 after selling out during the quarter.
Standard Family Office sold 22 Medpace shares in Q4 2022, an estimated $3K.
Standard Family Office first reported a position in Medpace in Q2 2022 and held it in 2 quarters.
Standard Family Office's Medpace position peaked at $3K in Q3 2022.
422 funds tracked by Wall St. Rank held Medpace as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.